GlaxoSmithKline has withdrawn an application in Europe relating to a combination treatment for melanoma, after the European Medicines Agency said more information was needed.
from WSJ.com: US Business http://ift.tt/1jumVjn
via IFTTT
from WSJ.com: US Business http://ift.tt/1jumVjn
via IFTTT
No comments:
Post a Comment